Fluorescence Imaging/Agents in Tumor Resection
Open Access
- 1 October 2017
- journal article
- review article
- Published by Elsevier BV in Neurosurgery Clinics of North America
- Vol. 28 (4), 569-583
- https://doi.org/10.1016/j.nec.2017.05.009
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- 5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-EnhancementPLOS ONE, 2013
- Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization ApproachPLOS ONE, 2012
- Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgeryJournal of Neuro-Oncology, 2012
- Gross Total Resection of Glioma with the Intraoperative Fluorescence-guidance of Fluorescein SodiumInternational Journal of Medical Sciences, 2012
- 5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective studyActa Neurochirurgica, 2011
- Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parametersJournal of Neurosurgery, 2011
- Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgeryJournal of Biomedical Optics, 2011
- Fluorescence lifetime imaging microscopy for brain tumor image-guided surgeryJournal of Biomedical Optics, 2010
- Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patientsNeuro-Oncology, 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006